about
The role of epigenetics in kidney malignanciesDLC1 suppresses NF-κB activity in prostate cancer cells due to its stabilizing effect on adherens junctionsModulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectivesVisualizing the prostate gland by MR imaging in young and old miceA phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer.Effects of chronic exposure to arsenic and estrogen on epigenetic regulatory genes expression and epigenetic code in human prostate epithelial cellsDiagnostic and prognostic utility of a DNA hypermethylated gene signature in prostate cancer.Male reproductive cancers and infertility: a mutual relationship.Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progressionHuman prostatic acid phosphatase: structure, function and regulation.Knockdown of RNF2 induces cell cycle arrest and apoptosis in prostate cancer cells through the upregulation of TXNIP.Global DNA hypomethylation in prostate cancer development and progression: a systematic review.Identification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory network.DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects.TET1-mediated different transcriptional regulation in prostate cancer.Heterogeneous patterns of DNA methylation-based field effects in histologically normal prostate tissue from cancer patients.Emerging putative biomarkers: the role of alpha 2 and 6 integrins in susceptibility, treatment, and prognosis.Prostate cancer health disparities: An immuno-biological perspective.Incorporating DNA Methyltransferase Inhibitors (DNMTis) in the Treatment of Genitourinary Malignancies: A Systematic Review.Role of androgen receptor splice variants in prostate cancer metastasis.Genetics and biology of prostate cancer
P2860
Q26801233-35620B45-F316-4655-86C0-1BCE8E759E2CQ28382965-643A7833-7FBC-49F7-8FEF-427D3BE988DAQ30570945-C67B8BEA-551B-4D19-98C9-DFC434E0EED2Q30597000-55AA3CB9-AF7D-4A8A-9B17-A50168B0A46FQ33408846-43661264-5765-4F4D-9B93-5F73C1338895Q34405780-041C2231-BD02-4ACF-9C75-FF8EFC53AC0BQ35120213-CEDD29D5-CB84-4AF2-9DC8-4005F6094204Q35585478-CA58016C-FFE7-4036-839A-758BB23DA880Q36345181-ACEBB798-B16C-4A49-AFEA-CA1B7F2BB721Q36913762-E83E5950-D0C3-4B53-B087-C8D7750ED2A5Q37706349-0C02365F-C33F-4A97-9404-6C08DCB2C6A8Q38266607-8732FEA7-27C5-44F7-9093-0961267720E5Q38657057-03413EDC-E55E-450C-A166-1C6194A846C4Q38833395-877B5CC0-CC77-4066-89E1-F754371C4903Q41790357-8BBA602B-4BF2-47CD-A805-7E18A3E584B1Q42256326-B0CDF9D7-4B36-47BA-9A03-94A38AAA5834Q42268071-F6DB13AA-CD43-4EE1-8D6C-185E829A0393Q46537204-38B64381-1022-4419-B63A-421898A63BE5Q48136845-A38829F8-7446-4CB0-B414-94FD80FED4C3Q53749556-22A632CF-C413-453C-8CF8-2853D5485135Q57106917-467E0478-7F85-4C85-B145-0B0F2BB0976D
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Epigenetics in prostate cancer.
@ast
Epigenetics in prostate cancer.
@en
type
label
Epigenetics in prostate cancer.
@ast
Epigenetics in prostate cancer.
@en
prefLabel
Epigenetics in prostate cancer.
@ast
Epigenetics in prostate cancer.
@en
P2093
P2860
P356
P1433
P1476
Epigenetics in prostate cancer.
@en
P2093
Ajjai S Alva
Ana M Aparicio
Costantine Albany
Guru Sonpavde
Noah M Hahn
Rakesh Singal
Sarvari Yellapragada
P2860
P304
P356
10.1155/2011/580318
P577
2011-11-30T00:00:00Z